Exhale

The official blog of the Lung Institute.

Discover How COPD Treatment Changed One Patient’s Life

1 May 2018
| Under COPD, Patient Stories | Posted by | 0 Comments

Chronic obstructive pulmonary disease (COPD) is notorious for causing shortness of breath and discomfort and for ultimately leading to respiratory failure. Patients who have been diagnosed with COPD may feel hopeless, but for patients like Vaneta H., COPD treatment restores hope. COPD is an incurable disease, but treatments can help improve your quality of life…

Read More >

What Causes Fibrosis of the Lungs?

5 Apr 2018
| Under Disease Education, FAQs, Lung Disease | Posted by | 0 Comments
What causes fibrosis of the lungs

Pulmonary fibrosis is a chronic lung disease that thickens and hardens the lung passageways responsible for carrying oxygen into the bloodstream. It can cause shortness of breath even with minimal activity.

Read More >

4 Tips for Easier Traveling with COPD

1 Mar 2018
| Under COPD, Lifestyle, Tips | Posted by | 0 Comments
4 Tips for Easier Traveling with COPD

Though it can be fun to spend some time away from home, when you have chronic obstructive pulmonary disease (COPD), getting from one location to another can be a little more complex. Fortunately, there are a few things you can do to make travel easier, and here are four tips that can help.

Read More >

Lifetime TV’s “Access Health” Touts Lung Institute’s Cellular Therapy

Lifetime_TV’s_Access_Health_Touts_Lung_Institute’s_Cellular_Therapy

The Lung Institute got a chance to tell its remarkable story to a national television audience in early November. Lifetime TV’s “Access Health” featured Dr. James St. Louis, Lung Institute senior medical advisor, discussing the innovative cellular therapy that has helped many people address the progression of their COPD and do more than just temporarily…

Read More >

How Do Non-Smokers Get Pulmonary Fibrosis?

18 Nov 2017
| Under Pulmonary Fibrosis | Posted by | 18 Comments
How do non-smokers get pulmonary fibrosis?

How do non-smokers get pulmonary fibrosis? While the specific cause may be unknown, there are a few possible causes. Learn more about pulmonary fibrosis causes and treatments here.

Read More >

Is Lung Restoration Treatment an Invasive Procedure?

15 Nov 2017
| Under Treatments | Posted by | 12 Comments
CellularTherapy__Easy_as_a_Blood_Draw_Blog-FB-1

Since we use your own cells to treat and slow down the progression of COPD, side effects are nearly nonexistent. Cellular therapy has demonstrated the potential to improve quality of life to those who may have otherwise given up hope.

Read More >

Insurance Companies: Will They Cover Cellular Therapy for COPD?

9 Nov 2017
| Under Medical, Resources | Posted by | 3 Comments
Why_Doesnt_Insurance_Cover_Treatment

You have a lung disease and you have exhausted all the options your doctor has recommended. You’ve heard about the Lung Institute and its remarkable cellular therapy where 84 percent of patients with COPD report an improved quality of life within three months of treatment. So, what’s the problem?

Read More >

Why Doesn’t the FDA Approve Our Cellular Treatment?

2 Nov 2017
| Under Disease Education, Resources, Treatments | Posted by | 16 Comments
Why Doesn't the FDA Approve Our Cellular Therapy?

You are concerned that cellular treatment for lung disease is not approved by the FDA. Our cellular treatments use your body’s (autologous) very own cells, so they do not fall under FDA scrutiny.

Read More >

Is COPD a Progressive Disease?

8 Aug 2017
| Under COPD, Lung Disease | Posted by | 4 Comments
Lung Graphic

Chronic obstructive pulmonary disease, or COPD, is a progressive condition that is characterized by respiratory difficulties. Oftentimes, COPD results from a persistent cycle of emphysema and chronic bronchitis — emphysema causes the alveoli (air sacs in the lungs) to lose elasticity, and chronic bronchitis causes the bronchioles (air passages) to become inflamed, leading to increased…

Read More >

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.